MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.amjcard.2021.07.034

Медицинская библиотека · The American journal of cardiology · 2021

Outcomes of Implantable Loop Monitoring in Patients <21 Years of Age.

Czosek Richard J, Zang Huaiyu, Baskar Shankar, Anderson Jeffrey B, Knilans Timothy K, Ollberding Nicholas J, Spar David S

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Rhythm-symptom correlation in pediatric patients with syncope/palpitations or at risk cohorts can be difficult, but important given potential associations with treatable or malignant arrhythmia. We sought to evaluate the use, efficacy and outcomes of implantable loop recorders (ILR) in pediatrics. We conducted a retrospective study of pediatric patients (<21 years) with implanted ILR. Patient/historical characteristics and ILR indication were obtained. Outcomes including symptom documentation, arrhythmia detection and ILR based changes in medical care were identified. Comparison of outcomes were performed based on implant indication. Additional sub-analyses were performed in syncope-indication patients comparing those with and without changes in clinical management. A total of 116 patients with ILR implant were identified (79 syncope/37 other). Symptoms were documented 58% of patients (syncope 68% vs nonsyncope 35%; p = 0.002). A total of 37% of patients had a documented clinically significant arrhythmia and 25% of patients had a resultant change in clinical management independent of implant indication. Arrhythmia type was dependent on implant indication with nonsyncope patients having more ventricular arrhythmias. Pacemaker/defibrillator implantation and mediation management were the majority of the clinical changes. In conclusion, IRL utilization in selected pediatric populations is associated with high efficacy and supports clinical management. ILR efficacy is similar regardless of indication although patients with nonsyncope indications had a higher frequency of ventricular arrhythmias as opposed to asystole and heart block in syncope indications. The majority of arrhythmic findings occurred in the first 12 months, and new technology that would allow for less invasive monitoring for 6 to 12 months may be of value.

Для цитирования: Czosek Richard J, Zang Huaiyu, Baskar Shankar, Anderson Jeffrey B, Knilans Timothy K, Ollberding Nicholas J, Spar David S. Outcomes of Implantable Loop Monitoring in Patients <21 Years of Age.. The American journal of cardiology. 2021. DOI: 10.1016/j.amjcard.2021.07.034.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.